These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 29788204)

  • 1. Rabies Antibody Response After Booster Immunization: A Systematic Review and Meta-analysis.
    Langedijk AC; De Pijper CA; Spijker R; Holman R; Grobusch MP; Stijnis C
    Clin Infect Dis; 2018 Nov; 67(12):1932-1947. PubMed ID: 29788204
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibody response in Dutch marines to a single intramuscular rabies booster immunization 1-2.5 years after an intradermal pre-exposure schedule: An observational study.
    De Pijper CA; Terryn S; Van Gucht S; Grobusch MP; Goorhuis A; Stijnis C
    Travel Med Infect Dis; 2020; 38():101907. PubMed ID: 33157228
    [No Abstract]   [Full Text] [Related]  

  • 3. Rabies pre-exposure prophylaxis elicits long-lasting immunity in humans.
    Mansfield KL; Andrews N; Goharriz H; Goddard T; McElhinney LM; Brown KE; Fooks AR
    Vaccine; 2016 Nov; 34(48):5959-5967. PubMed ID: 27997343
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early rabies antibody response to intramuscular booster in previously intradermally immunized travelers using human diploid cell rabies vaccine.
    Gherardin AW; Scrimgeour DJ; Lau SC; Phillips MA; Kass RB
    J Travel Med; 2001; 8(3):122-6. PubMed ID: 11468113
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative Immunogenicity and Safety Trial of 2 Different Schedules of Single-visit Intradermal Rabies Postexposure Vaccination.
    Soentjens P; De Koninck K; Tsoumanis A; Herssens N; Van Den Bossche D; Terryn S; Van Gucht S; Van Damme P; Van Herrewege Y; Bottieau E
    Clin Infect Dis; 2019 Aug; 69(5):797-804. PubMed ID: 30566636
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term anti-rabies antibody persistence following intramuscular or low-dose intradermal vaccination of young Vietnamese children.
    Vien NC; Feroldi E; Lang J
    Trans R Soc Trop Med Hyg; 2008 Mar; 102(3):294-6. PubMed ID: 18191971
    [TBL] [Abstract][Full Text] [Related]  

  • 7. One-dose intradermal rabies booster enhances rabies antibody production and avidity maturation.
    Kewcharoenwong C; Freeouf S; Nithichanon A; Petsophonsakul W; Pornprasert S; Khamduang W; Suzuki T; Onodera T; Takahashi Y; Lertmemongkolchai G
    Med Microbiol Immunol; 2024 May; 213(1):7. PubMed ID: 38761268
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Trend of human rabies prophylaxis in developing countries: toward optimal rabies immunization.
    Permpalung N; Wongrakpanich S; Korpaisarn S; Tanratana P; Angsanakul J
    Vaccine; 2013 Aug; 31(38):4079-83. PubMed ID: 23845809
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Route of Administration of Rabies Vaccines: Comparing the Data.
    Briggs DJ; Moore SM
    Viruses; 2021 Jun; 13(7):. PubMed ID: 34199111
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A single center, open label study of intradermal administration of an inactivated purified chick embryo cell culture rabies virus vaccine in adults.
    Recuenco S; Warnock E; Osinubi MOV; Rupprecht CE
    Vaccine; 2017 Aug; 35(34):4315-4320. PubMed ID: 28688782
    [TBL] [Abstract][Full Text] [Related]  

  • 11. One or three intradermal injections within one week for rabies pre-exposure immunization.
    Khawplod P; Wilde H; Sriaroon C; Chomchey P; Kamolthum T; Sitprija V
    Dev Biol (Basel); 2008; 131():393-401. PubMed ID: 18634501
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Persistence of antibodies in children after intradermal or intramuscular administration of preexposure primary and booster immunizations with purified Vero cell rabies vaccine.
    Sabchareon A; Chantavanich P; Pasuralertsakul S; Pojjaroen-Anant C; Prarinyanupharb V; Attanath P; Singhasivanon V; Buppodom W; Lang J
    Pediatr Infect Dis J; 1998 Nov; 17(11):1001-7. PubMed ID: 9849982
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rabies post-exposure prophylaxis: A systematic review on abridged vaccination schedules and the effect of changing administration routes during a single course.
    Kessels J; Tarantola A; Salahuddin N; Blumberg L; Knopf L
    Vaccine; 2019 Oct; 37 Suppl 1():A107-A117. PubMed ID: 30737043
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term Memory Response After a Single Intramuscular Rabies Booster Vaccination 10-24 Years After Primary Immunization.
    De Pijper CA; Langedijk AC; Terryn S; Van Gucht S; Grobusch MP; Goorhuis A; Stijnis C
    J Infect Dis; 2022 Sep; 226(6):1052-1056. PubMed ID: 33502530
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Persistence of rabies antibody 5 years after postexposure prophylaxis with vero cell antirabies vaccine and antibody response to a single booster dose.
    Zhang X; Zhu Z; Wang C
    Clin Vaccine Immunol; 2011 Sep; 18(9):1477-9. PubMed ID: 21752947
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibody response after a four-site intradermal booster vaccination with cell-culture rabies vaccine.
    Tantawichien T; Benjavongkulchai M; Limsuwan K; Khawplod P; Kaewchompoo W; Chomchey P; Sitprija V
    Clin Infect Dis; 1999 May; 28(5):1100-3. PubMed ID: 10452642
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serologic Response of 2 Versus 3 Doses and Intradermal Versus Intramuscular Administration of a Licensed Rabies Vaccine for Preexposure Prophylaxis.
    Endy TP; Keiser PB; Wang D; Jarman RG; Cibula D; Fang H; Ware L; Abbott M; Thomas SJ; Polhemus ME
    J Infect Dis; 2020 Apr; 221(9):1494-1498. PubMed ID: 31802120
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intradermal rabies pre-exposure vaccination schedules in older travellers: comparison of immunogenicity post-primary course and post-booster.
    Furuya-Kanamori L; Ramsey L; Manson M; Gilbert B; Lau CL
    J Travel Med; 2020 Nov; 27(7):. PubMed ID: 31943042
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rabies neutralizing antibody after 2 intradermal doses on days 0 and 21 for pre-exposure prophylaxis.
    Wongsaroj P; Udomchaisakul P; Tepsumethanon S; Khawplod P; Tantawichien T
    Vaccine; 2013 Mar; 31(13):1748-51. PubMed ID: 23370149
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Survival of neutralizing antibody in previously rabies vaccinated subjects: a prospective study showing long lasting immunity.
    Suwansrinon K; Wilde H; Benjavongkulchai M; Banjongkasaena U; Lertjarutorn S; Boonchang S; Suttisri R; Khowplod P; Daviratanasilpa S; Sitprija V
    Vaccine; 2006 May; 24(18):3878-80. PubMed ID: 16530893
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.